| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |